New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 4, 2014
10:23 EDTPODDInsulet bond offering 'financially sound,' says Leerink
Leerink says Insulet's $175M convertible bond offering due in 2019 is "financially sound" as it avoids potentially meaningful share dilution based on the principal of the existing convert. The firm reiterates an Outperform rating on the stock with a $45 price target.
News For PODD From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
January 28, 2015
09:26 EDTPODDLeerink medical devices analyst holds an analyst/industry conference call
Medical Devices Analyst Antalffy assesses the rapidly-evolving diabetes landscape and the potential growth trajectory for Insulet's OmniPod and DexCom's CGM on an Analyst/Industry conference call to be held on January 29 at 2 pm.
January 26, 2015
10:00 EDTPODDOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
06:53 EDTPODDInsulet downgraded to Market Perform from Outperform at William Blair
William Blair downgraded Insulet to Market Perform citing weaker domestic insulin pump market trends.
January 21, 2015
07:31 EDTPODDInsulet well positioned to beat expectations, says Leerink
Leerink believes the worst is now behind Insulet and that the company is positioned for accelerating new patient adds in Q2 and beyond. Leerink thinks lowered base expectations position Insulet to potentially top forecasts in 2015. The firm lowered its price target for shares to $40 and $50 and keeps an Outperform rating on the name.
January 16, 2015
11:49 EDTPODDInsulet sell-off yesterday overdone, says Leerink
Leerink attributes the sell-off yesterday in shares of Insulet to a downgrade at another firm, which questioned the company's growth in new patient additions. After speaking with management, Leerink thinks that Insulet's patient growth dip in Q1 was heavily influenced by seasonality and that "literally nothing has changed" in terms of end user pump market dynamics. The firm thinks yesterday's pullback was overdone and recommends the shares by bought on the weakness. Leerink maintains its Outperform rating on Insulet, but noted that its model is under review.
07:48 EDTPODDInsulet price target lowered to $39 from $50 at Oppenheimer
Oppenheimer cut its price target on Insulet after the company reported that the increase in the number of its diabetes patients came in below expectations. The firm thinks the company's FY15 guidance may be conservative, while the company has a number of potential positive catalysts. The firm thinks the stock is in the show-me stage but keeps an Outperform rating on the shares.
January 15, 2015
10:00 EDTPODDOn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: American Campus (ACC) downgraded to Sell from Neutral at Goldman... Apple (AAPL) downgraded to Neutral from Buy at Mizuho... Archer Daniels (ADM) downgraded to Neutral from Buy at Goldman... Barrick Gold (ABX) downgraded to Underweight from Equal Weight at Barclays... CNOOC (CEO) downgraded to Underperform from Hold at Jefferies... CSC (CSC) downgraded to Underweight from Neutral at JPMorgan... Computer Programs (CPSI) downgraded to Market Perform from Outperform at William Blair... D.R. Horton (DHI) downgraded to Neutral from Buy at UBS... DDR Corp. (DDR) downgraded to Neutral from Overweight at JPMorgan... Dominion Diamond (DDC) downgraded to Equal Weight from Overweight at Barclays... EVERTEC (EVTC) downgraded to Neutral from Overweight at JPMorgan... Education Realty (EDR) downgraded to Sell from Neutral at Goldman... Franco-Nevada (FNV) downgraded to Underweight from Equal Weight at Barclays... General Cable (BGC) downgraded to Neutral from Buy at Longbow... Green Dot (GDOT) downgraded to Neutral from Overweight at JPMorgan... Greif (GEF) downgraded to Neutral from Buy at BofA/Merrill... Grupo Simec (SIM) downgraded to Neutral from Buy at Goldman... Hecla Mining (HL) downgraded to Hold from Buy at BB&T... Host Hotels (HST) downgraded to Hold from Buy at MLV & Co.... Ingredion (INGR) downgraded to Sell from Neutral at Goldman... Insulet (PODD) downgraded to Market Perform from Outperform at Raymond James... Johnson & Johnson (JNJ) downgraded to Sell from Neutral at Goldman... Magna (MGA) downgraded to Hold from Buy at TD Securities... Molson Coors (TAP) downgraded to Neutral from Buy at Goldman... Nuverra Environmental (NES) downgraded at Roth Capital... Omnicom (OMC) downgraded to Hold from Buy at Evercore ISI... PetroChina (PTR) downgraded to Underperform from Hold at Jefferies... Philip Morris (PM) downgraded to Sell from Neutral at Goldman... Precision Castparts (PCP) downgraded to Hold from Buy at KeyBanc... Rio Tinto (RIO) downgraded to Neutral from Outperform at Macquarie... STAG Industrial (STAG) downgraded to Neutral from Overweight at JPMorgan... Silicon Laboratories (SLAB) downgraded to Equal Weight from Overweight at Barclays... Sinopec (SNP) downgraded to Underperform from Hold at Jefferies... Sky (SKYAY) downgraded to Neutral from Outperform at Exane BNP Paribas... Teledyne (TDY) downgraded to Underweight from Hold at KeyBanc... Woodward (WWD) downgraded to Underweight from Hold at KeyBanc... Xilinx (XLNX) downgraded to Equal Weight from Overweight at Barclays.
09:15 EDTPODDOn The Fly: Pre-market Movers
Subscribe for More Information
08:03 EDTPODDInsulet downgraded to Neutral from Overweight at JPMorgan
Subscribe for More Information
07:50 EDTPODDInsulet downgraded to Market Perform from Outperform at Raymond James
Raymond James downgraded Insulet to Market Perform following the recent negative pronouncement and slower growth.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use